Copyright
©The Author(s) 2019.
World J Gastroenterol. May 14, 2019; 25(18): 2229-2239
Published online May 14, 2019. doi: 10.3748/wjg.v25.i18.2229
Published online May 14, 2019. doi: 10.3748/wjg.v25.i18.2229
Figure 1 Hepatitis C genotype and presence/absence of cirrhosis for patients.
GT1: Genotype 1.
Figure 2 Hepatitis C virus RNA results for patients completing treatment with sustained virologic response.
- Citation: Loo N, Lawitz E, Alkhouri N, Wells J, Landaverde C, Coste A, Salcido R, Scott M, Poordad F. Ombitasvir/paritaprevir/ritonavir + dasabuvir +/- ribavirin in real world hepatitis C patients. World J Gastroenterol 2019; 25(18): 2229-2239
- URL: https://www.wjgnet.com/1007-9327/full/v25/i18/2229.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i18.2229